Sponsor Pipeline

Advenchen Laboratories, LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03016819 Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma… Alveolar Soft Part Sarcoma Recruiting
Phase 1/2
NCT07392736 A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced… Solid Tumor Recruiting
Phase 1
NCT06794957 A Study of AL8326 in Non-Small Cell Lung Cancer Non-small Cell Lung Cancer Active, Not Recruiting
Disease Areas
Sarcoma (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Advenchen Laboratories, LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free